President and CEO of MAP Pharmaceuticals, Inc. (MAPP) Timothy S Nelson sells 80,000 shares of MAPP on 01/23/2013 at an average price of $24.76 a share.

Map Pharmaceuticals, Inc. has a market cap of $873.1 million; its shares were traded at around $24.74 with and P/S ratio of 213.

This is the annual revenues and earnings per share of MAPP over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of MAPP.

CEO Recent Trades:

• President and CEO Timothy S Nelson sold 80,000 shares of MAPP stock on 01/23/2013 at the average price of 24.76. Timothy S Nelson owns at least 33,017 shares after this. The price of the stock has decreased by 0.08% since.

This is the insider trade history vs. stock price of MAPP. For the complete insider trading history of MAPP, click here.

Directors and Officers Recent Trades:

• Chief Scientific Officer Thomas A Armer sold 59,620 shares of MAPP stock on 01/23/2013 at the average price of 24.76. Thomas A Armer owns at least 129,162 shares after this. The price of the stock has decreased by 0.08% since.
• SVP, Chief Business Officer Anastasios Gianakakos sold 30,000 shares of MAPP stock on 01/23/2013 at the average price of 24.76. Anastasios Gianakakos owns at least 14,330 shares after this. The price of the stock has decreased by 0.08% since.
• Director Geraldine Henwood sold 5,240 shares of MAPP stock on 11/23/2012 at the average price of 15. The price of the stock has increased by 64.93% since.
• SVP, Chief Business Officer Anastasios Gianakakos sold 5,767 shares of MAPP stock on 11/01/2012 at the average price of 15.64. Anastasios Gianakakos owns at least 12,385 shares after this. The price of the stock has increased by 58.18% since.

For the complete insider trading history of MAPP, click here.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool